bicalutamide and cyproterone acetate

bicalutamide has been researched along with cyproterone acetate in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (9.52)	18.7374
1990's	11 (26.19)	18.2507
2000's	19 (45.24)	29.6817
2010's	8 (19.05)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ackerman, JH; Bell, MR; Christiansen, RG; D'Ambra, TE; Herrmann, JL; Kullnig, RK; Mallamo, JP; Opalka, CJ; Snyder, BW; Winneker, RC	1
Edwards, JP; Farmer, LJ; Hamann, LG; Higuchi, RI; Jones, TK; Kong, JW; Marschke, KB; Wang, XN; Zhi, L	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Schröder, FH	2
Mowszowicz, I	1
Furr, BJ	2
Daricello, G; Pavone, C; Pavone-Macaluso, M; Romano, C; Serretta, V	1
Ebert, K; Knuppen, R; Michna, H; Vollmer, G	1
Berrevoets, CA; Mulder, E; Veldscholte, J	1
McLeod, DG	1
Matzkin, H; Soloway, MS	1
Schellhammer, PF	1
Bonnet, P	1
Chang, C; Miyamoto, H; Wilding, G; Yeh, S	1
Bloemena, E; Hage, JJ; Kanhai, RC; Mulder, JW; van Diest, PJ	1
Lumbroso, S; Moras, D; Nicolas, JC; Poujol, N; Sultan, C; Tahiri, B; Wurtz, JM	1
Collette, L; Denis, LJ; Schröder, FH; Studer, UE; Sylvester, RJ	1
Baniahmad, A; Cato, AC; Dotzlaw, H; Iñiguez Lluhí, JA; Mink, S; Moehren, U	1
Jänne, OA; Karvonen, U; Palvimo, JJ	1
Skarda, J	1
Cardi, A; Di Silverio, F; Sciarra, A	1
Jänne, OA; Kang, Z; Palvimo, JJ	1
Bai, C; Chen, F; Freedman, L; Gambone, C; Harada, S; Kasparcova, V; Knecht, K; Leu, C; Reszka, A; Rutledge, SJ; Scafonas, A; Schmidt, A; Vogel, R; Zhang, H	1
Baltogiannis, D; Charalabopoulos, K; Giannakopoulos, X; Sofikitis, N	1
Benney, M; Gillatt, DA; Okeke, AA; Sugiono, M; Winkler, MH	1
Akinmade, D; Brodie, A; Goloubeva, O; Hamburger, AW; Jelovac, D; Nakanishi, T; Ross, DD; Wang, XW; Yu, MH; Zhang, Y	1
Hidalgo, A; Manso, G; Revuelta, P; Salgueiro, E; Thole, Z	1
Asim, M; Baniahmad, A; Dotzlaw, H; Papaioannou, M; Reeb, C	1
Cecchini, MG; Klima, I; Peternac, D; Studer, UE; Thalmann, GN	1
Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T	1
De Rosier, T; Eliason, HC; Ervin, KM; Gowda, K; Kupcho, KR; Marks, BD; Ozers, MS; Qadir, N; Riddle, SM; Shekhani, MS	1
Bach, T; Blana, A; Ganzer, R; Rössler, W; Wieland, WF	1
Hara, S; Hyochi, N; Isaacs, JT; Ishioka, J; Kageyama, Y; Kihara, K; Singh, P; Urushibara, M	1
Dubbink, HJ; Hersmus, R; Jenster, G; Lusher, SJ; Molier, M; Trapman, J; van de Wijngaart, DJ	1
Jääskeläinen, T; Kauhanen, M; Makkonen, H; Palvimo, JJ	1
Brian, J; Green, C; Jobling, S; Kanda, R; Scholze, M; Williams, R	1
Begum, S; Bevan, CL; Brooke, GN; Bryan, RA; Dart, DA; Fioretti, FM; Gamble, SC; Hough, MA; Odontiadis, M; Powell, SM; Wait, R; Waxman, J	1

Reviews

9 review(s) available for bicalutamide and cyproterone acetate

Article	Year
Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma. Progress in clinical and biological research, 1990, Volume: 359 Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds	1990
[Antiandrogens. Mechanisms and paradoxical effects]. Annales d'endocrinologie, 1989, Volume: 50, Issue:3 Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Anilides; Cimetidine; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Nitriles; Spironolactone; Tosyl Compounds	1989
Antiandrogenic drugs. Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl Topics: Androgen Receptor Antagonists; Anilides; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Megestrol; Megestrol Acetate; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds	1993
Antiandrogenic agents as monotherapy in advanced prostatic carcinoma. Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Neoplasm Staging; Nitriles; Prognosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds	1993
The place and the results of monotherapy. Acta urologica Belgica, 1998, Volume: 66, Issue:2 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds	1998
Antiandrogens as monotherapy for prostate cancer. European urology, 1998, Volume: 34 Suppl 3 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds	1998
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer. Urologia internationalis, 2004, Volume: 72, Issue:2 Topics: Androgen Antagonists; Anilides; Chemotherapy, Adjuvant; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Orchiectomy; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Tosyl Compounds	2004
Monotherapy in advanced prostate cancer: an overview. Experimental oncology, 2004, Volume: 26, Issue:3 Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Nitriles; Orchiectomy; Palliative Care; Progesterone Congeners; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testosterone; Tosyl Compounds	2004
[Hormonal treatment of cancer of the prostate: review and present status]. Deutsche medizinische Wochenschrift (1946), 2007, Jan-26, Volume: 132, Issue:4 Topics: Administration, Oral; Androgen Antagonists; Anilides; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Clinical Trials, Phase III as Topic; Confidence Intervals; Cyproterone Acetate; Disease Models, Animal; Dogs; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Meta-Analysis as Topic; Multicenter Studies as Topic; Nitriles; Orchiectomy; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Testosterone; Time Factors; Tosyl Compounds	2007

Trials

2 trial(s) available for bicalutamide and cyproterone acetate

Article

Year

Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.

Progress in clinical and biological research, 1990, Volume: 359

Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds

1990

Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer--a pilot study.

Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:1

Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Cyproterone Acetate; Goserelin; Humans; Injections, Subcutaneous; Male; Nitriles; Pain; Prostatic Neoplasms; Tosyl Compounds

2005

Other Studies

32 other study(ies) available for bicalutamide and cyproterone acetate

Article	Year
Antiandrogenic steroidal sulfonylpyrazoles. Journal of medicinal chemistry, 1990, Volume: 33, Issue:8 Topics: Androgen Antagonists; Animals; Male; Molecular Structure; Orchiectomy; Organ Size; Pregnanes; Prostate; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Androgen; Structure-Activity Relationship; Testosterone; X-Ray Diffraction	1990
Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines. Journal of medicinal chemistry, 1998, Feb-12, Volume: 41, Issue:4 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Animals; Cell Line; COS Cells; Dihydropyridines; Dihydrotestosterone; Gonadotropins; Heterocyclic Compounds; Humans; Indicators and Reagents; Male; Molecular Structure; Orchiectomy; Prostate; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Receptors, Progesterone; Recombinant Proteins; Seminal Vesicles; Structure-Activity Relationship; Testosterone; Transfection	1998
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Dogs; Flutamide; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Rats; Tosyl Compounds	1989
[Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate]. Archivos espanoles de urologia, 1989, Volume: 42 Suppl 2 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Flutamide; Follow-Up Studies; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Neoplasm Staging; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds	1989
ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen. Progress in clinical and biological research, 1988, Volume: 260 Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Dogs; Flutamide; Imidazoles; Imidazolidines; Male; Nitriles; Prostate; Radioligand Assay; Rats; Receptors, Androgen; Seminal Vesicles; Testosterone; Tosyl Compounds	1988
Androgen ablation induces tenascin expression in the rat prostate. The Prostate, 1994, Volume: 25, Issue:2 Topics: Androgen Antagonists; Anilides; Animals; Cell Adhesion Molecules, Neuronal; Cyproterone Acetate; Extracellular Matrix Proteins; Flutamide; Male; Nitriles; Orchiectomy; Prostate; Rats; Rats, Wistar; Tenascin; Testosterone; Tosyl Compounds	1994
Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 46, Issue:6 Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Androgen Antagonists; Anilides; Animals; Blotting, Western; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Male; Metribolone; Mutagenesis, Site-Directed; Nitriles; Point Mutation; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins; Threonine; Tosyl Compounds; Transcription, Genetic; Transfection; Transformation, Genetic; Tumor Cells, Cultured	1993
Fulminant hepatic failure associated with bicalutamide. Urology, 1997, Volume: 50, Issue:5 Topics: Androgen Antagonists; Anilides; Cyproterone Acetate; Flutamide; Hepatic Encephalopathy; Humans; Nitriles; Tosyl Compounds	1997
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proceedings of the National Academy of Sciences of the United States of America, 1998, Jun-23, Volume: 95, Issue:13 Topics: Androgen Antagonists; Androgens; Anilides; Cyproterone Acetate; Drug Interactions; Flutamide; Humans; Imidazoles; Male; Mifepristone; Nitriles; Nuclear Receptor Coactivators; Oncogene Proteins; Prostatic Neoplasms; Protein Binding; Protein Conformation; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured	1998
Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men. The American journal of surgical pathology, 2000, Volume: 24, Issue:1 Topics: Adult; Aged; Androgen Antagonists; Anilides; Breast; Castration; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Gynecomastia; Humans; Male; Mastectomy, Subcutaneous; Metaplasia; Nitriles; Orchiectomy; Time Factors; Tosyl Compounds; Transsexualism	2000
Specific recognition of androgens by their nuclear receptor. A structure-function study. The Journal of biological chemistry, 2000, Aug-04, Volume: 275, Issue:31 Topics: Amino Acid Sequence; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Binding Sites; Computer Simulation; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Ligands; Metribolone; Models, Molecular; Molecular Sequence Data; Nitriles; Progesterone; Promegestone; Receptors, Androgen; Sequence Alignment; Tosyl Compounds; Transcriptional Activation	2000
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences. The Prostate, 2001, Jun-15, Volume: 48, Issue:1 Topics: Androgen Antagonists; Anilides; Clinical Trials, Phase III as Topic; Cyproterone Acetate; Factor Analysis, Statistical; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Meta-Analysis as Topic; Nitriles; Orchiectomy; Prognosis; Prostatic Neoplasms; Research Design; Survival Analysis; Tosyl Compounds; Treatment Outcome	2001
The amino terminus of the human AR is target for corepressor action and antihormone agonism. Molecular endocrinology (Baltimore, Md.), 2002, Volume: 16, Issue:4 Topics: Androgen Antagonists; Anilides; Animals; Catalytic Domain; Cell Line; Cyclic AMP-Dependent Protein Kinases; Cyproterone Acetate; DNA-Binding Proteins; Flutamide; Haplorhini; Humans; Ligands; Male; Nitriles; Nuclear Receptor Co-Repressor 2; Point Mutation; Protein Conformation; Receptors, Androgen; Repressor Proteins; Tosyl Compounds; Transcriptional Activation; Transfection	2002
Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. FEBS letters, 2002, Jul-17, Volume: 523, Issue:1-3 Topics: Active Transport, Cell Nucleus; Androgen Antagonists; Androgens; Anilides; Animals; Cell Nucleus; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Flutamide; Nitriles; Nuclear Receptor Coactivator 2; Receptors, Androgen; Subcellular Fractions; Tosyl Compounds; Transcription Factors; Transcriptional Activation	2002
Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine, 2003, Volume: 50, Issue:4 Topics: Androgen Antagonists; Anilides; Animals; Animals, Outbred Strains; Biological Assay; Chlormadinone Acetate; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Flutamide; Male; Mammary Glands, Animal; Mice; Mice, Inbred C3H; Nitriles; Norethindrone; Norethindrone Acetate; Orchiectomy; Progesterone; Seminal Vesicles; Spleen; Steroids; Tosyl Compounds	2003
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:11 Topics: Acetylation; Androgen Receptor Antagonists; Anilides; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyproterone Acetate; DNA Polymerase II; Enhancer Elements, Genetic; Gene Expression Regulation; Histones; Humans; Male; Methylation; Mifepristone; Nitriles; Nuclear Proteins; Nuclear Receptor Coactivator 2; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Protein-Arginine N-Methyltransferases; Receptors, Androgen; Tissue Kallikreins; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcription, Genetic	2004
Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 91, Issue:4-5 Topics: Adaptor Proteins, Signal Transducing; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Androstenediol; Androstenedione; Anilides; Animals; Breast Neoplasms; Carrier Proteins; Cell Division; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dihydrotestosterone; Humans; Ligands; Macaca mulatta; Male; Mammary Tumor Virus, Mouse; Mice; Nerve Tissue Proteins; Nitriles; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, AMPA; Receptors, Androgen; Tosyl Compounds; Transcription, Genetic; Tumor Cells, Cultured	2004
The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 2005, Jul-12, Volume: 102, Issue:28 Topics: Adaptor Proteins, Signal Transducing; Androgen Antagonists; Anilides; Animals; Blotting, Western; Carrier Proteins; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyproterone Acetate; DNA Primers; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Humans; Luciferases; Male; Mice; Mice, SCID; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Receptor, ErbB-3; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Tosyl Compounds	2005
Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Androgen Antagonists; Anilides; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Flutamide; Humans; International Classification of Diseases; Liver Diseases; Nitriles; Retrospective Studies; Spain; Time Factors; Tosyl Compounds	2006
Co-activator and co-repressor interplay on the human androgen receptor. Andrologia, 2005, Volume: 37, Issue:6 Topics: Androgen Antagonists; Androgen-Binding Protein; Androgens; Anilides; Cyproterone Acetate; Flutamide; Humans; Ligands; Male; Nitriles; Protein Binding; Receptors, Androgen; Repressor Proteins; Response Elements; Time Factors; Tosyl Compounds; Trans-Activators; Transcriptional Activation	2005
Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth. The Journal of urology, 2006, Volume: 176, Issue:1 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyproterone Acetate; DNA, Complementary; Goserelin; Humans; Male; Nitriles; Polymerase Chain Reaction; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Tosyl Compounds	2006
Ligand-specific dynamics of the androgen receptor at its response element in living cells. Molecular and cellular biology, 2007, Volume: 27, Issue:5 Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic	2007
The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Biochemistry, 2007, Jan-23, Volume: 46, Issue:3 Topics: Amino Acid Sequence; Amino Acid Substitution; Androgen Antagonists; Anilides; Animals; Cyproterone Acetate; Dihydrotestosterone; Fluoresceins; Fluorescence Resonance Energy Transfer; Flutamide; Ligands; Mifepristone; Nitriles; Oligopeptides; Rats; Receptors, Androgen; Tosyl Compounds	2007
Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors. The Prostate, 2007, Jun-01, Volume: 67, Issue:8 Topics: Allylestrenol; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cyproterone Acetate; Flutamide; Humans; Imidazolidines; Male; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms, Hormone-Dependent; Nitriles; Plasmids; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Testosterone; Tosyl Compounds; Transcription, Genetic; Transfection	2007
Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H. The Journal of biological chemistry, 2010, Feb-12, Volume: 285, Issue:7 Topics: Androgen Antagonists; Anilides; Blotting, Western; Cell Line, Tumor; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Humans; Hydrocortisone; Hydrophobic and Hydrophilic Interactions; Male; Mutation; Nitriles; Progesterone; Prostatic Neoplasms; Protein Structure, Secondary; Receptors, Androgen; Steroids; Structure-Activity Relationship; Tosyl Compounds	2010
Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells. Molecular and cellular endocrinology, 2011, Jan-01, Volume: 331, Issue:1 Topics: Androgens; Anilides; Cell Line, Tumor; Chromatin; Cyproterone Acetate; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Metribolone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Transcription, Genetic	2011
Environmental concentrations of anti-androgenic pharmaceuticals do not impact sexual disruption in fish alone or in combination with steroid oestrogens. Aquatic toxicology (Amsterdam, Netherlands), 2015, Volume: 160 Topics: Androgen Antagonists; Anilides; Animals; Cyprinidae; Cyproterone Acetate; Disorders of Sex Development; Estradiol; Estrogens; Ethinyl Estradiol; Male; Nitriles; Oryzias; Rivers; Sewage; Sexual Development; Tosyl Compounds; Vitellogenins; Water Pollutants, Chemical	2015
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells. Molecular & cellular proteomics : MCP, 2015, Volume: 14, Issue:5 Topics: Amino Acid Sequence; Androgen Antagonists; Anilides; Cell Line, Tumor; Cyproterone Acetate; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Sequence Annotation; Molecular Sequence Data; Mutation; Nandrolone; Neoplasm Proteins; Nitriles; Prostate; Proteome; Receptors, Androgen; Signal Transduction; Tosyl Compounds	2015